ITMN transfers Actimmune manufacturing

InterMune (ITMN) said the FDA has approved the transfer of manufacturing for its Actimmune interferon gamma-1b to treat chronic granulomatous disease (CGD) and severe malignant osteopetrosis to Boehri...